Agenus maintains a world footprint via collaborations and partnerships with leading pharmaceutical and biotechnology businesses in North The united states, Europe and Asia. Its agreements include research and development collaborations, license arrangements and co-development courses targeted at accelerating the translation of novel immunotherapies